Article citationsMore >>

H. C. Lin, P. L. Lu, and C. H. Chang, “Uveitis associated with concurrent administration of rifabutin and lopinavir/ritonavir (Kaletra),” Eye (Lond), 12, pp. 1540-1, England, 2007.

has been cited by the following article:

Article

Rifabutin low dose-induced intermediate uveitis in a patient with Acquired Immunodeficiency Syndrome

1Department of Ophthalmology, Consultores Oftalmológicos, Buenos Aires, Argentina

2Department of infectology, Hospital General de Agudos Juan A. Fernandez, Buenos Aires, Argentina


American Journal of Medical Case Reports. 2017, Vol. 5 No. 5, 116-118
DOI: 10.12691/ajmcr-5-5-3
Copyright © 2017 Science and Education Publishing

Cite this paper:
Agustina C. Palacio, Mercedes Cabrini, Graciela Ben, Emilio M. Dodds. Rifabutin low dose-induced intermediate uveitis in a patient with Acquired Immunodeficiency Syndrome. American Journal of Medical Case Reports. 2017; 5(5):116-118. doi: 10.12691/ajmcr-5-5-3.

Correspondence to: Emilio  M. Dodds, Department of Ophthalmology, Consultores Oftalmológicos, Buenos Aires, Argentina. Email: emdodds@gmail.com

Abstract

Intermediate uveitis is a relatively rare manifestation of Rifabutin induced uveitis. Rifabutin toxicity is unusual at doses of 300 mg daily or less. The purpose of this study is to report the case of an HIV+ patient with unilateral rifabutin induced intermediate uveitis after 4 months of treatment with low dose rifabutin (150 mg daily) in combination with ritonavir and fluconazole. The uveitis resolved after drug discontinuance and the use topical corticosteroids.

Keywords